Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Anthony David Elias

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Elias, Anthony

One or more keywords matched the following items that are connected to Elias, Anthony

Item Type	Name
Academic Article	Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Academic Article	Phase II study of topotecan in metastatic non-small-cell lung cancer.
Academic Article	Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections.
Academic Article	Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
Academic Article	Small cell lung cancer: state-of-the-art therapy in 1996.
Academic Article	The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses.
Academic Article	Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome.
Academic Article	Hematopoietic stem cell transplantation for small cell lung cancer.
Academic Article	Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
Academic Article	Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Academic Article	A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
Academic Article	Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
Academic Article	Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.
Academic Article	Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Academic Article	A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.
Academic Article	Adjuvant chemotherapy for soft tissue sarcoma: an approach in search of an effective regimen.
Academic Article	The era of high-dose chemotherapy for breast cancer: revisiting a troubled quest.
Academic Article	Chemotherapy of advanced soft-tissue sarcomas.
Academic Article	Salvage therapy for soft tissue sarcomas.
Academic Article	Future directions in lung cancer research and therapeutics.
Academic Article	A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
Academic Article	Outcome of patients with metastatic breast carcinoma treated at a private medical oncology clinic.
Academic Article	Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Academic Article	Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
Academic Article	Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Academic Article	Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
Concept	Antineoplastic Agents, Alkylating
Concept	Antineoplastic Agents
Concept	Antineoplastic Agents, Hormonal
Academic Article	Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
Academic Article	Trabectedin: novel insights in the treatment of advanced sarcoma.
Academic Article	Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Academic Article	Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.
Academic Article	Management of young breast cancer patients with de novo genetic mutations.
Academic Article	Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.
Academic Article	Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
Academic Article	Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen.
Academic Article	A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer.
Academic Article	Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.
Academic Article	Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).
Academic Article	NCCN Guidelines Updates: Breast Cancer.
Academic Article	A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Academic Article	Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Academic Article	Male breast cancer: a disease distinct from female breast cancer.
Concept	Antineoplastic Agents, Immunological
Academic Article	Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.
Academic Article	Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification.
Academic Article	Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway.

Search Criteria

Antineoplastic Agents